20 June 2013
Keywords: idec, antibody, begun, phase, ii, trial, its
Article | 16 May 1994
IDEC has begun a Phase II trial of its recombinant pan-B antibody,
IDEC-C2B8, in combination with chemotherapy for the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 May 1994
9 May 1994
19 June 2013
© 2013 thepharmaletter.com